Tag: cannabis
Manufacturing deal signed between Bioxyne and Aurora Cannabis for medicinal products
Bioxyne Limited has announced a new manufacturing agreement with Aurora Cannabis Inc., placing manufacturing at the center of a partnership aimed at supplying pharmaceutical-grade cannabis products to multiple international markets.
Bioxyne signs $5.6M supply agreement to enter German medical cannabis market
Bioxyne Limited), through its subsidiary Breathe Life Sciences (BLS), has entered the German medical cannabis market by securing a commercial supply agreement worth a minimum of €3.2 million (approximately AUD 5.6 million) for FY2026.
ECS Botanics secures a 4-year agreement with MW Pharma Limited
Australian medicinal cannabis and industrial hemp company ECS Botanics has signed a four-year agreement to supply GMP manufactured medicinal cannabis products to MW Pharma...
ECS Botanics acquires medical cannabis cultivator Murray Meds
ECS Botanics Holdings Ltd (ASX:ECS) is poised to acquire advanced medical cannabis cultivator Murray Meds after signing a binding Term Sheet with Flowerday Holding...
Leafcann Group Granted All Three Medicinal Cannabis Licences in Australia
Media Release
LeafCann Group Pty Ltd (LeafCann) is pleased to announce that it has received its Australian Cannabis Research and Medicinal Cannabis (Cultivation) licences from...
Victoria will supply half of Australia’s medicinal cannabis by 2028
Victoria will supply half of Australia’s medicinal cannabis by 2028 according to Australia’s first ever Medical Cannabis Industry Development Strategy which was unveiled last...
Featured Article
What spending reveals about downstream consumer demand for manufactured goods
For manufacturers supplying consumer-facing markets, understanding demand conditions has become increasingly important in an environment shaped by cautious spending, rising costs and intense competition.
